Search research articles
Contact Us
Filters
Showing results (281-290 of 382) with videos related to
Page
of 39
Sort By:
Hemasphere
|
April 10, 2023
Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant
Aung M Tun, Yucai Wang, Aasiya Matin, et al.
Leukemia & Lymphoma
|
August 20, 2005
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma
Yinlee Yoong, Luis F Porrata, David J Inwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource
Brian K Link, Matthew J Maurer, Grzegorz S Nowakowski, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 9, 2022
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience
Justin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation
Abhishek Singla, William J Hogan, Stephen M Ansell, et al.
Blood
|
February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
Blood
|
April 30, 2015
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma
Thomas E Witzig, Craig Reeder, Jing Jing Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma
Jane N Winter, David J Inwards, Stewart Spies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 5, 2012
Interobserver reliability in the histopathological diagnosis of cartilaginous tumors in patients with multiple osteochondromas
Carlos E de Andrea, Herman M Kroon, Ron Wolterbeek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study
Grzegorz S Nowakowski, Betsy LaPlant, William R Macon, et al.
Page
of 39
Search research articles
Search
Showing results (281-290 of 382) with videos related to
Sort By:
Page
of 39
Hemasphere
|
April 10, 2023
Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant
Aung M Tun, Yucai Wang, Aasiya Matin, et al.
Leukemia & Lymphoma
|
August 20, 2005
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma
Yinlee Yoong, Luis F Porrata, David J Inwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource
Brian K Link, Matthew J Maurer, Grzegorz S Nowakowski, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 9, 2022
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience
Justin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation
Abhishek Singla, William J Hogan, Stephen M Ansell, et al.
Blood
|
February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
Blood
|
April 30, 2015
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma
Thomas E Witzig, Craig Reeder, Jing Jing Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma
Jane N Winter, David J Inwards, Stewart Spies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 5, 2012
Interobserver reliability in the histopathological diagnosis of cartilaginous tumors in patients with multiple osteochondromas
Carlos E de Andrea, Herman M Kroon, Ron Wolterbeek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study
Grzegorz S Nowakowski, Betsy LaPlant, William R Macon, et al.
Page
of 39